Cardiovascular Outcomes With Sodium-Glucose Cotransporter 2 Inhibitors in Ethnically Diverse Patients With Heart Failure

More on SGLT2 inhibitors

• Inflammatory burden is linked to incident heart failure

  medRxiv · 4 Oct 2026

  

• ARNI links to lower osteoporosis risk in heart failure

  Internal and Emergency Medicine · 4 Oct 2026

• SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs

  Diabetes & Vascular Disease Research · 4 Oct 2026

• SGLT2 inhibitors raise genital but not urinary infection risk

  Clinical Pharmacology and Therapeutics · 4 Oct 2026